Non-genetic nanodevice shows spatiotemporal control of receptor interactions in MCF-7 cells, highlighting apoptosis mechanisms.
Plasmon resonance energy transfer (PRET) faces critical challenges in achieving precise molecular-scale distance control and non-perturbative operation within single live-cell environments, e.g., the inability to dynamically tune the donor-acceptor distance (r) at the single molecular dipole level. To overcome these bottlenecks, we designed a non-genetic, non-fluorescent PRET nanodevice integrating a single gold nanoparticle donor (ErbB3-targeting antibody@GNP), a single molecular dipole acceptor (ErbB2-targeting aptamer@TAMRA), and a programmable nucleic acid spacer (nTA). This spacer enables precise in situ control of r (2.7 nm vs 7.2 nm) on the single-living MCF-7 cell membrane. At r ≈ 2.7 nm (PRET-ON), ErbB2-ErbB3 heterodimerization occurs, suppressing apoptosis. At r ≈ 7.2 nm (PRET-OFF), receptor dissociation activates caspase-9-mediated apoptosis via suppression of the AKT pathway suppression. This distance-tunable single molecular dipole PRET nanodevice overcomes membrane fluidity constraints, eliminates photobleaching artifacts, and provides long-term, single-cell resolution, establishing a potential universal platform for spatiotemporally controlling receptor interactions and downstream signaling.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: